Institution
International Centre for Diarrhoeal Disease Research, Bangladesh
Facility•Dhaka, Bangladesh•
About: International Centre for Diarrhoeal Disease Research, Bangladesh is a facility organization based out in Dhaka, Bangladesh. It is known for research contribution in the topics: Population & Vibrio cholerae. The organization has 3103 authors who have published 5238 publications receiving 226880 citations. The organization is also known as: SEATO Cholera Research Laboratory & Bangladesh International Centre for Diarrhoeal Disease Research.
Topics: Population, Vibrio cholerae, Cholera, Public health, Health care
Papers published on a yearly basis
Papers
More filters
••
[...]
TL;DR: In order to enable women who use drugs to access life-saving services including needle-syringe and condom programs, opioid substitution therapy and HIV testing and treatment, it is essential to create a conducive environment and provide tailor-made services that are adapted to their specific needs.
113 citations
••
TL;DR: Caution should be exercised when supplementing undernourished infants with a single micronutrient, as the mental development index scores of the zinc-treated group were slightly but significantly lower than those of the placebo group.
113 citations
••
TL;DR: Overall As methylation in women in early pregnancy was remarkably efficient, probably because women, especially in pregnancy and with low folate intake, have an efficient betaine-mediated remethylation of homocysteine, which is essential for an efficient As methylations.
Abstract: Worldwide, millions of people are exposed to inorganic arsenic (iAs), a documented potent human toxicant and carcinogen, via drinking water [International Agency for Research on Cancer (IARC) 2004; World Health Organization (WHO)/International Programme on Chemical Safety 2001]. The British Geological Survey (BGS 2001) estimated that about 50 million people in Bangladesh alone are drinking water from tube wells that exceeds the WHO drinking-water guideline value for As of 10 μg/L. There is a marked variation in susceptibility to As, which—at least in part—may be mediated via variation in As metabolism (Vahter 2002).
iAs is metabolized by most mammals, including humans, via reduction and methylation reactions with S-adenosylmethionine (SAM) as the methyl donor (Hayakawa et al. 2005; Marafante and Vahter 1984; Vahter 2002). Dimethylarsinic acid (DMA) is the main As metabolite excreted in human urine, besides monomethylarsonic acid (MMA) and some remaining iAs, but there are major differences among individuals as well as between population groups (Vahter 2002). Usually, the proportions are 10–30% iAs, 10–20% MMA, and 60–80% DMA (Vahter 2002). The metabolism of As implies both detoxification and activation. The reduced trivalent forms, in particular MMA(III), are more toxic than the pentavalent forms (Bredfeldt et al. 2006; Schwerdtle et al. 2003; Styblo et al. 2002; Wang et al. 2007). A high concentration of MMA in the urine indicates a low capacity of further methylation to DMA and, probably, elevated concentrations of the highly toxic MMA(III) in the cells. There is increasing evidence of positive associations between urinary MMA and the prevalence of As-related bladder cancer (Chen et al. 2003b; Pu et al. 2007; Steinmaus et al. 2006), skin cancer (Chen et al. 2003a; Hsueh et al. 1997; Yu et al. 2000), other skin effects (Ahsan et al. 2007; Del Razo et al. 1997), structural chromosomal aberrations (Maki-Paakkanen et al. 1998), cardiovascular effects (Tseng et al. 2005), and increased retention of ingested As (Vahter 2002). Thus, it is essential to identify the mechanisms behind the wide interindividual variation in As metabolism.
Because As is methylated through one-carbon metabolism (Figure 1), it is likely that the availability of methyl groups via intake of protein (Lammon and Hood 2004; Marafante and Vahter 1984; Vahter and Marafante 1987) and other factors involved in the methylation cycles [e.g. folate and vitamin B12 (Spiegelstein et al. 2003; Spiegelstein et al. 2005)] are critical for As methylation. There is also experimental evidence for the involvement of essential trace elements such as selenium and zinc (De Kimpe et al. 1999; Hong et al. 2000; Walton et al. 2003), although the mechanisms are not clear. Because of the marked species differences in As methylation (Vahter 1999), it is difficult to extrapolate the results to humans. However, there is growing evidence for a nutritional regulation of As methylation in humans (Gamble et al. 2005, 2006, 2007; Heck et al. 2007; Steinmaus et al. 2005). In the present study, we aimed to elucidate the modifying effects of macronutrient status, assessed by body mass index [BMI; body weight (kg) ÷ height (m2)], and micronutrient status, assessed by biomarkers of folate, vitamin B12, Zn, ferritin, and Se status, on As metabolism in pregnant Bangladeshi women with a wide range of nutritional status and As exposure via drinking water.
Figure 1
Overview of one-carbon metabolism and the methylation of As. Abbreviations: 5,10-CH2-THF, methylene tetrahydrofolate; AS3MT, As methyltransferase; DMG, dimethylglycine; GAA, guanidinoacetate; MTHFR, 5,10-CH2-THF reductase; SAH, S-adenosylhomocysteine; ...
113 citations
••
TL;DR: Before developing countries reinforce home-based births with a skilled attendant, research is needed to compare the feasibility, cost, effectiveness, acceptability, and implications for health-care equity in both approaches.
113 citations
••
TL;DR: Lack of evidence for mortality impact despite high program coverage and quality assurance of implementation, and improvements in targeted newborn care practices suggests the intervention did not adequately address risk factors for mortality.
Abstract: BACKGROUND: To evaluate a delivery strategy for newborn interventions in rural Bangladesh. METHODS: A cluster-randomized controlled trial was conducted in Mirzapur Bangladesh. Twelve unions were randomized to intervention or comparison arm. All women of reproductive age were eligible to participate. In the intervention arm community health workers identified pregnant women; made two antenatal home visits to promote birth and newborn care preparedness; made four postnatal home visits to negotiate preventive care practices and to assess newborns for illness; and referred sick neonates to a hospital and facilitated compliance. Primary outcome measures were antenatal and immediate newborn care behaviours knowledge of danger signs care seeking for neonatal complications and neonatal mortality. FINDINGS: A total of 4616 and 5241 live births were recorded from 9987 and 11153 participants in the intervention and comparison arm respectively. High coverage of antenatal (91% visited twice) and postnatal (69% visited on days 0 or 1) home visitations was achieved. Indicators of care practices and knowledge of maternal and neonatal danger signs improved. Adjusted mortality hazard ratio in the intervention arm compared to the comparison arm was 1.02 (95% CI: 0.80-1.30) at baseline and 0.87 (95% CI: 0.68-1.12) at endline. Primary causes of death were birth asphyxia (49%) and prematurity (26%). No adverse events associated with interventions were reported. CONCLUSION: Lack of evidence for mortality impact despite high program coverage and quality assurance of implementation and improvements in targeted newborn care practices suggests the intervention did not adequately address risk factors for mortality. The level and cause-structure of neonatal mortality in the local population must be considered in developing interventions. Programs must ensure skilled care during childbirth including management of birth asphyxia and prematurity and curative postnatal care during the first two days of life in addition to essential newborn care and infection prevention and management. TRIAL REGISTRATION: Clinicaltrials.gov NCT00198627.
113 citations
Authors
Showing all 3121 results
Name | H-index | Papers | Citations |
---|---|---|---|
Stanley Falkow | 134 | 349 | 62461 |
Myron M. Levine | 123 | 789 | 60865 |
Roger I. Glass | 116 | 474 | 49151 |
Robert F. Breiman | 105 | 473 | 43927 |
Harry B. Greenberg | 100 | 433 | 34941 |
Barbara J. Stoll | 100 | 390 | 42107 |
Andrew M. Prentice | 99 | 550 | 46628 |
Robert H. Gilman | 96 | 903 | 43750 |
Robert E. Black | 92 | 201 | 56887 |
Johan Ärnlöv | 91 | 386 | 90490 |
Juan Jesus Carrero | 89 | 522 | 66970 |
John D. Clemens | 89 | 506 | 28981 |
William A. Petri | 85 | 507 | 26906 |
Toshifumi Hibi | 82 | 808 | 28674 |
David A. Sack | 80 | 437 | 23320 |